EP2150249 - Bibliographic data
USE OF BENZO-FUSED HETEROCYCLE SULFAMIDE DERIVATIVES FOR THE TREATMENT OF MIGRAINE
Last update | 23/07/2025 |
---|---|
Legal status | Brevet déchu |
Origin | Euro-PCT |
(73) Holder |
JANSSEN PHARMACEUTICA N.V. Turnhoutseweg 30
2340 Beerse
Belgique
|
---|---|
(72) Inventors |
SMITH-SWINTOSKY, Virginia L. 3163 Line Lexington Road
Hatfield, PA 19440
États-Unis d'Amérique
|
(74) Agent |
Mail recipient WARNER, JAMES ALEXANDER ET AL Carpmaels & Ransford One Southampton Row
London WC1A 2RA
Royaume-Uni
|
(21) Request number | EP07757059.6 |
---|---|
(22) Request date | 15/02/2007 |
(11) Publication number | EP2150249 |
---|---|
Publication date | 24/04/2013 |
(54) Title of the invention | USE OF BENZO-FUSED HETEROCYCLE SULFAMIDE DERIVATIVES FOR THE TREATMENT OF MIGRAINE |
---|---|
(51) International classification | A61K 31/353, A61K 31/357, A61K 31/36, A61P 25/06 |
International classification (before reform) | None |
Claimed priority |
(31) Number: 773764 P
(31) Number: 674021 |
---|---|
Initial application | None |
Divisional application | None |
Expected annuity |
Annuity: 8 -
Amount: 105 € -
Due date 28/02/2014
Surtax: 8 - Amount: 21 € - Due date 01/09/2014 |
---|---|
Last annuity | None |
Publication | BREVETS D'INVENTION DESIGNANT MC DELIVRES PAR l'OEB - bulletin 2013/2, of 30/06/2013 |
---|---|
History | Publication de la délivrance du brevet européen - Legal date 24/04/2013 Entrée en période de grâce du brevet d'invention - Legal date 01/03/2014 Déchéance du brevet d'invention après période de grâce - Legal date 28/02/2014 |